# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Vilazodone | 29 | Ki | = | 28 | nM | ALA5217327 | 7.55 | nM | Homo sapiens | ||
2. | Vilazodone | 29 | IC50 | = | 25 | nM | ALA5217326 | 7.60 | nM | Rattus norvegicus | ||
3. | Vilazodone | 29 | CLH | = | 60.6 | microL/min/mg | ALA5217325 | mL.min-1.g-1 | ||||
4. | Vilazodone | 29 | t1/2 | = | 23.08 | min | ALA5217324 | hr | ||||
5. | Vilazodone | 29 | CLH | = | 51.59 | microL/min/mg | ALA5217323 | mL.min-1.g-1 | ||||
6. | Vilazodone | 29 | t1/2 | = | 26.87 | min | ALA5217322 | hr | ||||
7. | Vilazodone | 29 | INH | = | 29 | % | ALA5165168 | % | Homo sapiens | |||
8. | Vilazodone | 29 | INH | = | 51.3 | % | ALA5165167 | % | Homo sapiens | |||
9. | Vilazodone | 29 | INH | = | 49.2 | % | ALA5165166 | % | Homo sapiens | |||
10. | Vilazodone | 29 | INH | = | 14.4 | % | ALA5165165 | % | Homo sapiens | |||
11. | Vilazodone | 29 | CLH | = | 49.3 | microL/min/mg | ALA5165164 | mL.min-1.g-1 | ||||
12. | Vilazodone | 29 | t1/2 | = | 28.1 | min | ALA5165163 | hr | ||||
13. | Vilazodone | 29 | IC50 | = | 5.6 | uM | ALA5165162 | 5.25 | nM | Homo sapiens | ||
14. | Vilazodone | 29 | IC50 | = | 0.4 | nM | ALA5165150 | 9.40 | nM | Homo sapiens | ||
15. | Vilazodone | 29 | IC50 | > | 200 | uM | ALA5165149 | nM | Homo sapiens | |||
16. | Vilazodone | 29 | Activity | = | 60 | % | ALA4409679 | % | Mus musculus | |||
17. | Vilazodone | 29 | CLH | = | 26 | uL/min/ug | ALA4409669 | mL.min-1.g-1 | ||||
18. | Vilazodone | 29 | t1/2 | = | 53.32 | min | ALA4409668 | hr | ||||
19. | Vilazodone | 29 | CLH | = | 48.59 | uL/min/ug | ALA4409667 | mL.min-1.g-1 | ||||
20. | Vilazodone | 29 | t1/2 | = | 28.52 | min | ALA4409666 | hr |